These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18665927)

  • 1. 4-thio-deoxyuridylate-modified thrombin aptamer and its inhibitory effect on fibrin clot formation, platelet aggregation and thrombus growth on subendothelial matrix.
    Mendelboum Raviv S; Horváth A; Aradi J; Bagoly Z; Fazakas F; Batta Z; Muszbek L; Hársfalvi J
    J Thromb Haemost; 2008 Oct; 6(10):1764-71. PubMed ID: 18665927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel nucleotide-based thrombin inhibitor inhibits clot-bound thrombin and reduces arterial platelet thrombus formation.
    Li WX; Kaplan AV; Grant GW; Toole JJ; Leung LL
    Blood; 1994 Feb; 83(3):677-82. PubMed ID: 8298130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA Aptamers to Thrombin Exosite I. Structure-Function Relationships and Antithrombotic Effects.
    Spiridonova VA; Novikova TM; Sizov VA; Shashkovskaya VS; Titaeva EV; Dobrovolsky AB; Zharikova EB; Mazurov AV
    Biochemistry (Mosc); 2019 Dec; 84(12):1521-1528. PubMed ID: 31870256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity.
    Bompiani KM; Monroe DM; Church FC; Sullenger BA
    J Thromb Haemost; 2012 May; 10(5):870-80. PubMed ID: 22385910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood.
    Barstad RM; Kierulf P; Sakariassen KS
    Thromb Haemost; 1996 Apr; 75(4):685-92. PubMed ID: 8743200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis.
    Wilson SJ; Connolly TM; Peters G; Ghosh A; Johnson M; Newby DE
    Cardiovasc Res; 2019 Mar; 115(3):669-677. PubMed ID: 30184110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Effects of Anti-thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow Conditions.
    Derszniak K; Przyborowski K; Matyjaszczyk K; Moorlag M; de Laat B; Nowakowska M; Chlopicki S
    Front Pharmacol; 2019; 10():68. PubMed ID: 30842734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer inhibits degradation of platelet proteolytically activatable receptor, PAR-1, by thrombin.
    Boncler MA; Koziolkiewicz M; Watala C
    Thromb Res; 2001 Nov; 104(3):215-22. PubMed ID: 11672764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
    Liu CZ; Shih MH; Tsai PJ
    Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of endothelial cells induces platelet thrombus formation on their matrix. Studies of new in vitro thrombosis model with low molecular weight heparin as anticoagulant.
    Zwaginga JJ; Sixma JJ; de Groot PG
    Arteriosclerosis; 1990; 10(1):49-61. PubMed ID: 2297347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly efficient control of thrombin activity by multivalent nanoparticles.
    Hsu CL; Chang HT; Chen CT; Wei SC; Shiang YC; Huang CC
    Chemistry; 2011 Sep; 17(39):10994-1000. PubMed ID: 21850727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of thermally denatured fibrinogen on polyethylene with plasma proteins and platelets.
    Rubens F; Brash J; Weitz J; Kinlough-Rathbone R
    J Biomed Mater Res; 1992 Dec; 26(12):1651-63. PubMed ID: 1484068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model.
    Zavyalova E; Samoylenkova N; Revishchin A; Golovin A; Pavlova G; Kopylov A
    PLoS One; 2014; 9(9):e107113. PubMed ID: 25192011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen).
    Di Minno G; Martinez J; Cirillo F; Cerbone AM; Silver MJ; Colucci M; Margaglione M; Tauro R; Semeraro N; Quattrone A
    Arterioscler Thromb; 1991; 11(4):785-96. PubMed ID: 1829631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinopeptide A cleavage and platelet release in whole blood in vitro. Effects of stimuli, inhibitors, and agitation.
    Kaplan KL; Drillings M; Lesznik G
    J Clin Invest; 1981 May; 67(5):1561-8. PubMed ID: 6453136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of anticoagulants and the role of thrombin on neutrophil-endothelial cell interactions in septic shock.
    Tsen A; Kirschenbaum LA; LaRow C; Khan R; Kurtz S; Bansal S; Astiz ME
    Shock; 2009 Feb; 31(2):120-4. PubMed ID: 18636042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombus growth and embolism on tissue factor-bearing collagen surfaces under flow: role of thrombin with and without fibrin.
    Colace TV; Muthard RW; Diamond SL
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1466-76. PubMed ID: 22516070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits.
    Griffin LC; Tidmarsh GF; Bock LC; Toole JJ; Leung LL
    Blood; 1993 Jun; 81(12):3271-6. PubMed ID: 8507864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.